🇺🇸 FDA
Pipeline program

Bacteriophage

APT.PJI.006

Phase 2 small_molecule terminated

Quick answer

Bacteriophage for Prosthetic Joint Infection is a Phase 2 program (small_molecule) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Adaptive Biotechnologies Corp
Indication
Prosthetic Joint Infection
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials